Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499666 · ClinicalTrials.gov registry record
Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
A clinical trial, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- 15
- Enrollment target
NCT02499666: Clinical Trial study, sponsored by Henry Ford Health System.
NCT02499666 is a clinical trial that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02499666 was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)
Primary Outcome
Evaluate change in exercise capacity as determined by peak VO2 by comparing pre and post percutaneous intervention cardiopulmonary exercise test results
Interventions
- DRUG Clopidogrel
- PROCEDURE Percutaneous Coronary Intervention
- DEVICE Coronary stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-06-29 |
| Est. Completion | 2017-10-30 |
Why NCT02499666 stopped before completion
NCT02499666 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Clopidogrel is the first listed.
NCT02499666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02499666 about?
NCT02499666 is a clinical study titled "Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI". The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)
What is the current status of trial NCT02499666?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2015-06-29. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT02499666?
The interventions under investigation include: Clopidogrel (DRUG), Percutaneous Coronary Intervention (PROCEDURE), Coronary stent (DEVICE).
Who is sponsoring clinical trial NCT02499666?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI